From the Editor

1. Halozyme's Outsourcing Tip: The External Manufacturing Site Lead 4/11/2022

   Halozyme's API production has occurred at two U.S.-based CDMOs since its first commercial approval in 2013. The biotech works closely with both on new API generations and biologic processes, leading to additional regulatory filings. Here's a key ingredient to that success.

2. From J&J To Cognitive Psychology: Lifecycle Insights For Pharma 8/6/2015

   William King was a career J&J executive who decided he had to leave the company. Ironically, it was so he could devote himself to solving a growing challenge there. “We had these important ‘lifecycle insights’ that we couldn’t take action on, despite having all these data points coming in,” says the CEO of Zephyr Healthcare. 

3. Breaking News: Select Your CMO With Three (Well-Known) Attributes 8/3/2015

   Here’s your news bulletin: Another experienced source goes on record sharing three basics to selecting the best CMO: credibility, work ethic, and relationships. “I gained experience and understanding of outsourcing from running our own CRO,” says Chris K. Achar, CEO of Genzum Life Sciences.

4. BioPharma Fears CMO Capacity Crunch 7/24/2015

   Fear is discernable in the voices of executives at BioPharma companies when considering a capacity crunch at CMOs. There’s also a rising resignation. Getting on CMO production schedules and securing commitments is a here-and-now challenge.